Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Observational × Immunologic Tests × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Paraneoplastic Syndromes 1 Autoimmune Diseases of the Nervous System 1

Interventions

Surveys and Questionnaires 283 Blood Specimen Collection 144 Gene Expression Profiling 96 Interviews as Topic 83 Immunohistochemistry 78 Polymerase Chain Reaction 64 Surgical Procedures, Operative 62 Magnetic Resonance Spectroscopy 56 Microarray Analysis 55 Flow Cytometry 53 Radiotherapy 48 Amplified Fragment Length Polymorphism Analysis 48 Drug Therapy 46 Observation 44 Biopsy 42 Reverse Transcriptase Polymerase Chain Reaction 39 Bevacizumab 39 Data Collection 34 Sorafenib 29 Psychiatric Rehabilitation 29 Nivolumab 28 palbociclib 26 In Situ Hybridization, Fluorescence 26 Rituximab 25 Therapeutics 24 Hepatectomy 24 Colonoscopy 24 Sunitinib 23 Paclitaxel 23 Docetaxel 23

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05645185 2022-12-09

CarMa2

Hospices Civils de Lyon

Paraneoplastic Syndromes, Autoimmune Diseases of the Nervous System

Data powered by HemOnc (CC BY 4.0) Colophon ⚡